In the June issue of Diagnostic Imaging, we noted with approval the decision by the Society for Computer Applications in Radiology to change its name to the Society for Imaging Informatics in Medicine.
In the June issue of Diagnostic Imaging, we noted with approval the decision by the Society for Computer Applications in Radiology to change its name to the Society for Imaging Informatics in Medicine.
The imaging informatics picture is growing broader-encompassing more types of medical information, more specialists, and more parts of the medical enterprise-so it was appropriate that SCAR shift its name to the perhaps more sibilant SIIM.
The same rationale underlies our shift in the name of our PACS and Informatics supplement, now 10 years old, to Enterprise Imaging & IT. Over the years, we've watched as digital radiological images have moved further into the healthcare enterprise to become an ever more important part of the medical decision-making process. This diffusion has entailed some shifts in strategy and focus for radiologists and others involved in the digital management of images.
Our purpose in making this name change is to recognize these adjustments and make sure our coverage remains topical and closely tied to the realities of digital imaging practice.
We believe our readers are closely interested in imaging informatics, but imaging informatics now extends throughout the enterprise. Our readers' focus is expanding, and ours will as well.
-John C. Hayes is editor of Diagnostic Imaging
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.